NASDAQ:DFTX | News — Page 2 | Definium Therapeutics, Inc.

DFTX News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2021-08-17Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-08-13Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-08-13Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-08-13Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-08-12Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-08-04Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-07-28Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-07-13Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-07-08Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-06-24Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-06-21Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-06-09Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-28Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-28Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-26Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-25Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-20Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-19Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-18Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-14Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-13Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-05-06Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-04-28Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-04-27Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.
2021-04-23Foreign issuer reportSEC filingDefinium Therapeutics, Inc. filed Form 6-KDefinium Therapeutics, Inc. filed Form 6-K.